[1]
S. Lahiry, R. Sinha, S. Choudhury, and A. Mukherjee, “Breakthrough in Heart Failure therapy: LCZ696 combining ACE-Neprilysin inhibition”, Asian J Med Sci, vol. 8, no. 1, pp. 1–4, Jan. 2017.